General Information


DRAVP ID  DRAVPe00925

Peptide Name   T-201

Sequence  ALDPIDISIELNKAKSDLEESKEWIRRSNQKLDSI

Sequence Length  35

UniProt ID  P69353 

Source  Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)

Other Link  DRAVPa0364



Activity Information


Target Organism  HPIV-3

Assay  Cytopathic effect(CPE) assay

Activity 

  • [Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=0.1 μg/ml).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • [Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 μM).

Binding Target  Not found

Mechanism  No machanism information found in the reference(s) presented in this entry



Structure Information


PDB ID  None

Predicted Structure Download  DRAVPe00925

Linear/Cyclic  Linear

N-terminal Modification  Acetylation

C-terminal Modification  Amidation

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C176H293N49O60

Absent amino acids  CFGHMTVY

Common amino acids  IS

Mass  4055.55

Pl  4.77

Basic residues  6

Acidic residues  8

Hydrophobic residues  12

Net charge  -2

Boman Index  -9975

Hydrophobicity  -80.86

Aliphatic Index  106

Half Life 

  •     Mammalian:4.4 hour
  •     Yeast:>20 hour
  •     E.coli:>10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  161.76

Polar residues  7



Literature Information


Literature 1

Title   Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. 

Pubmed ID   8700906

Reference   Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.

Author   Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr.

DOI   10.1073/pnas.93.5.2186